Beijing Huaguan Biotechnology Co., Ltd., a pioneering force in synthetic biology and green chemical manufacturing, has officially closed its Series C financing round, securing hundreds of millions of RMB to accelerate its growth trajectory. This substantial capital infusion was driven by a
In a move that sends ripples across the global pharmaceutical landscape, AstraZeneca has committed to a landmark $15 billion investment in China, a strategic initiative designed to run through 2030. The announcement, made on January 29, 2026, signals a profound deepening of the company's research,
For decades, respiratory syncytial virus (RSV) was largely perceived as a threat to infants and the elderly. However, a seismic shift is underway, challenging this long-held view and repositioning RSV as a significant public health concern for a much broader adult population. Recent regulatory
The once-unbreakable bond between the United States and the World Health Organization has officially been severed, sending shockwaves through the global public health infrastructure and raising urgent questions about the future of international cooperation in an era of resurgent nationalism. This
The intricate molecular machinery that underpins all life has become a canvas for artificial intelligence, leading to a new era where biological catalysts can be designed from the ground up for specific human needs. A collaborative team from Graz University of Technology and the University of Graz
The quest for sustainable manufacturing has led scientists to an unlikely workforce: single-celled organisms meticulously reprogrammed to produce some of the world's most valuable chemicals. This burgeoning field of synthetic biology is unlocking the potential of microbes to serve as miniature,
